OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit – Outset Medical (NASDAQ:OM)

Photo of author

By Ronald Tech






Outset Medical, Inc. Facing Securities Fraud Lawsuit

Investors in OM Alert: Securities Fraud Lawsuit Beckons

LOS ANGELES, Sept. 6, 2024 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) OM.

Class Period: August 1, 2022August 7, 2024
Lead Plaintiff Deadline: October 28, 2024

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors crucial information about the marketing and approval processes of the Tablo products, leading to a potential halt in sales and revenue growth impact.

To be a member of the class action, no immediate action is required. Interested parties can choose legal representation or remain inactive while still being part of the lawsuit.

For further details or inquiries, contact Frank R. Cruz at The Law Offices of Frank R. Cruz in Century City, California, or visit their website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Market News and Data brought to you by Benzinga APIs



See also  The Rise of Super Micro Computer Inc: A Hidden Gem Outshining the Tech Giants